BNTX position history
The shares of Biontech (BNTX) that Krensavage Asset Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 120,000 shares, $11M, 4.9% of portfolio, New
- 2024 Q2: 132,293 shares, $11M, 4.9% of portfolio, Add +10.2%
- 2024 Q3: 93,583 shares, $11M, 6.2% of portfolio, Reduce −29.3%
- 2024 Q4: 182,246 shares, $20M, 12.0% of portfolio, Add +94.7%
- 2025 Q1: 87,563 shares, $8M, 4.4% of portfolio, Reduce −52.0%
- 2025 Q2: 73,382 shares, $7.8M, 4.1% of portfolio, Reduce −16.2%
- 2025 Q3: 79,366 shares, $7.8M, 3.3% of portfolio, Add +8.2%
- 2025 Q4: 99,523 shares, $9.5M, 3.3% of portfolio, Add +25.4%
- 2026 Q1: 59,523 shares, $5.3M, 2.1% of portfolio, Reduce −40.2%
- 2026 Q2: 59,523 shares, $5.5M, 2.1% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|